Appendix 4D and Half Year Report
Filed with ASX · · 28 pages · English
Story so far
Earlier from Immuron
- Presenting on Emerging Growth Conference 89 Day 2 on January 22; Register to live stream
- Immuron Reports Continued Sales Growth
- Uniformed Services University to Release Topline Data
- Immuron New U.S. Department of Defense Award & Clinical Trial Update
- Immuron IMM-529 IND approved by FDA
Later from Immuron
- Immuron Reports HY26 Results and Strategic Reset
- Strategic Update and HY26 Results
- Immuron CEO, Steven Lydeamore presentation at Coffee Microcaps Conference
- Immuron Double Digit 3Q Sales Growth
- Immuron FY26 Sales Update
Follow Immuron into a list and get an email when it puts out news.
Follow Immuron